Genomic organization of the human CYP3A locus: Identification of a new, inducible CYP3A gene

Pharmacogenetics

Volumn 11, Issue 2, 2001, Pages 111-121

  Gellner, K ^a   Eiselt, R ^a   Hustert, E ^a   Arnold, H ^a   Koch, I ^a   Haberl, M ^a   Deglmann, C J ^a   Burk, O ^a   Buntefuss, D ^a   Escher, S ^a   Bishop, C ^a   Koebe, H G ^a   Brinkmann, U ^a   Klenk, H P ^a   Kleine, K ^a   Meyer, U A ^a   Wojnowski, L ^a  

^a Epidauros Biotechnologie AG   (Germany)

Author keywords

CYP3A; CYP3A43; Induction; Splicing

Indexed keywords

CYTOCHROME P450 3A; CYTOCHROME P450 3A4; GENE PRODUCT; MESSENGER RNA; RIFAMPICIN;

ARTICLE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE LOCUS; GENE SEQUENCE; GENETIC ORGANIZATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MULTIGENE FAMILY; PRIORITY JOURNAL; RNA SPLICING; SEQUENCE HOMOLOGY; STEROID METABOLISM;

AMINO ACID SEQUENCE; ARYL HYDROCARBON HYDROXYLASES; BASE SEQUENCE; CHROMOSOME MAPPING; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; HUMANS; MOLECULAR SEQUENCE DATA; OXIDOREDUCTASES, N-DEMETHYLATING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIFAMPIN;

EID: 17744397194     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200103000-00002     Document Type: Article

References (35)

1. Ethnic differences in the pharmacokinetics of oral nifedipine
2. The influence of dose and ethnic origins on the pharmacokinetics of nifedipine
3. Population distribution and effects on drug metabolism of a genetic variant in the 5′ promoter region of CYP3A4
4. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction
5. Recent advances in understanding the molecular basis of polymorphisms in genes encoding cytochrome P450 enzymes
6. Pharmacogenomics: Translating functional genomics into rational therapeutics
7. Association of CYP3A4 genotype with treatment-related leukemia
8. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver
9. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module
10. Cytochrome P-450 3A4: Regulation and role in drug metabolism
11. Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control
12. Alternative splicing of CYP2D mRNA in human breast tissue
13. Assignment of the human cytochrome P-450 nifedipine oxidase gene (CYP3A4) to chromosome 7 at band q22.1 by fluorescence in situ hybridization
14. Multiple sequence alignment with Clustal X
15. Sequence of the 5′-flanking region of CYP3A5: Comparative analysis with CYP3A4 and CYP3A7
16. Detection of CYP3A5 allelic variant: A candidate for the polymorphtc expression of the protein?
17. Hypothesis: Comparisons of inter- and intra-individual variations can substitute for twin studies in drug research
18. Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam
19. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway
20. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
21. Evolution of the cytochrome P450 superfamily: Sequence alignments and pharmacogenetics
22. Substrates of human hepatic cytochrome P450 3A4
23. Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver
24. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature
25. Co-carcinogenic effect of beta-carotene
26. Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4
27. CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: Evidence for an allelic variant with altered catalytic activity
28. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver
29. Isolation of CYP3A5P cDNA from human liver: A reflection of a novel cytochrome P-450 pseudogene
30. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians
31. Alternative splicing in the control of gene expression
32. In vitro and in vivo drug interactions involving human CYP3A
33. Clinical implications of genetic polymorphisms and drug interactions mediated by cytochrome P-450 enzymes
34. Interindividual differences in hepatic expression of CYP3A4: Relationship to genetic polymorphism in the 5′-upstream regulatory region
35. Alternative splicing patterns of CYP2D genes in human brain and neurodegenerative disorders